Previous Close | 0.3100 |
Open | 0.3100 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 115.00 |
Expire Date | 2024-08-16 |
Day's Range | 0.3000 - 0.3100 |
Contract Range | N/A |
Volume | |
Open Interest | 17 |
Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.
In this article, we will discuss dividend stocks for regular income. You can skip our detailed analysis of dividend stocks and their historical performance, and go directly to read Dividend Stock Portfolio For Income: Top 5 Stocks. It is generally believed that dividend stocks are primarily suitable for people approaching retirement. However, this is far from […]
AbbVie ( NYSE:ABBV ) First Quarter 2024 Results Key Financial Results Revenue: US$12.3b (flat on 1Q 2023). Net income...